20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1869L | Antioxidant peptide A acetate | Antioxidant peptide A acetate (159147-88-3 free base) | Others |
Antioxidant peptide A acetate is a short peptide, which contains alternative aromatic or sulfur-containing amino acid. | |||
T40403 | Antioxidant 1024 | MD 1024 | |
Antioxidant 1024 (MD 1024) is an antioxidant agent and metal deactivator. | |||
T19633 | Ionox 330 | Antioxidant 40,BRN 2034522,Ahydol,Antioxidant 330,AO-40 | Others |
Ionox 330 (Ahydol) is an alkylphenol compound used as an antioxidant. | |||
TP1869 | Antioxidant peptide A | ||
Antioxidant peptide A is a short peptide, which contains alternative aromatic or sulfur-containing amino acid. | |||
T21238 | Antioxidant ZMB | Benzimidazolethiol zinc salt,Zinc mercaptobenzimidazolate,Mercaptobenzimidazole zinc salt,ZMB | |
Antioxidant ZMB, also named Benzimidazolethiol zinc salt,is an antioxidant. | |||
T20824 | Cyanox CY 1790 | Lowinox 1790,Irganox 3790,Antioxidant 1790,Irganox-3790,DN 90 | Others |
Cyanox CY 1790 (Irganox-3790) is an agent with antioxidant activity. | |||
T83027 | Antioxidant agent-17 | ||
Antioxidant agent-17 (compound 59) potently inhibits superoxide anion generation, exhibiting an IC50 value of 9.06 nM [1]. | |||
T61312 | Antioxidant agent-3 | ||
Antioxidant agent-3 (Compound 14q), a potent antioxidant, exhibits strong scavenging activity against DPPH radicals and ABTS+ radicals, with IC50 values of 26.58 μM and 30.31 μM, respectively. Additionally, it enhances t... | |||
T83028 | Antioxidant agent-16 | ||
Antioxidant Agent-16 (Product 2) exhibits potent antioxidant activity, as demonstrated by its IC50 value of 6.93 ppm [1]. | |||
T72511 | Antioxidant agent-7 | ||
Antioxidant Agent-7 (SD-7), a benzodiazepine derivative, exhibits antioxidant activity, demonstrated by its ability to scavenge the DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical with an IC50 value of 470 nM. | |||
T83029 | Antioxidant agent-14 | ||
Kaempferol glycoside, known as Antioxidant agent-14, has been isolated from the leaves of Brassica juncea [1]. | |||
T83026 | Antioxidant agent-18 | ||
Antioxidant Agent-18 (Compound 5), a flavonol glycoside derived from Ginkgo biloba, exhibits antioxidant properties through its ability to scavenge DPPH radicals (IC50: 15.8 μM) and reduce cytochrome c (IC50: 14.7 μM). | |||
T72471 | Antioxidant agent-2 | ||
Antioxidant agent-2 (comp 3c), a BBB-penetrating and selective metal ion chelator, exhibits significant neuroprotective and hepatoprotective effects, making it beneficial for Alzheimer’s disease research. | |||
T62111 | Antioxidant agent-5 | ||
Antioxidant agent-5 (compound D-6) is a potent antioxidant. antioxidant agent-5 inhibits oxLDL-induced increases in ROS levels and NF-κB nuclear translocation. antioxidant agent-5 inhibits oxLDL (oxidized LDL)-induced ap... | |||
T83030 | Antioxidant agent-11 | ||
Antioxidant Agent-11 (compound 3d) exhibits weak anti-cancer and antioxidant properties [1]. | |||
T76580 | Antioxidant agent-9 | ||
Antioxidant Agent-9, a peptide featuring the Asp-Trp sequence, exhibits antioxidant properties and demonstrates potential as an antiviral against SARS-CoV-2, possessing an affinity strength comparable to that of Chloroqu... | |||
T83031 | Antioxidant agent-10 | ||
Antioxidant Agent-10 (Compound 3) demonstrates moderate DPPH scavenging activity, possessing an EC50 value of 33.2 μg/mL [1]. | |||
T79915 | Antioxidant agent-15 | COX | |
Antioxidant agent-15 (Compound 4) demonstrates potent antioxidant inhibition activity, exhibiting an IC50 value of 15.44 nM. Furthermore, it effectively inhibits tumor cell growth in Hela, Hep G2, and Caco-2 cells, with ... | |||
T79331 | Antioxidant agent-13 | Xanthine Oxidase | |
Compound 5f (Antioxidant agent-13) is an antioxidant that demonstrates inhibition of DPPH and FRAP with half maximal inhibitory concentrations (IC50s) of 80.33 µM and 85.69 µM, respectively. Additionally, it inhibits the... | |||
T72506 | Antioxidant agent-8 | ||
Antioxidant agent-8 is an orally active compound that inhibits the deposition of Aβ 1-42 by preventing fibril aggregation (IC 50 =11.15 µM) and aiding in fibril disaggregation (IC 50 =6.87 µM). Moreover, it effectively c... |